Nature's Only Choice B1:7 Dietary Supplement Recall: Unapproved Drug Risk
Nature's Only Choice recalls B17 bitter raw apricot extract dietary supplement due to being classified as an unapproved new drug. Consumers should check product details and contact the company for guidance.
Recall notice
The Vitamin B17 containing product is considered to be a prescription drug, new drug, and unapproved new drug.
Contact the company
What happened, in plain English
Nature's Only Choice is recalling its B17 bitter raw apricot extract dietary supplement because it's considered an unapproved new drug. This poses a risk as it may not be safe for consumption without medical supervision. Read more at govinfonow.com/recall/19125-nature-s-only-choice-b1-7-dietary-supplement-recall-unapproved.
Source Summary by GovInfoNow · govinfonow.com/recall/19125-nature-s-only-choice-b1-7-dietary-supplement-recall-unapproved · Updated October 7, 2026 · FDA enforcement record: FDA #F-1480-2018
Cite this page
“Nature's Only Choice B1:7 Dietary Supplement Recall: Unapproved Drug Risk.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/19125-nature-s-only-choice-b1-7-dietary-supplement-recall-unapproved. Based on FDA recall #F-1480-2018 (https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-1480-2018%22&limit=1).
Why it’s dangerous
The product contains Vitamin B17, which is classified as an unapproved new drug. This means it has not been approved by regulatory authorities for safety and efficacy. Consuming it without medical supervision could lead to health risks.
Who’s affected
People who own or use this dietary supplement are affected. Those with medical conditions or taking other medications may be at higher risk.
How to tell if you have this one
Check for the product name 'Nature's Only Choice B17 BITTER RAW APRICOT EXTRACT AMYGDALIN Dietary Supplement 100 Capsules' with an expiration date of 06/2019.
- Brand
Nature's Only Choice- Category
Food
What to do — step by step
Check Product Details
Look for the product name and expiration date on the label to confirm if it's affected.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
FDA distribution: “Nationwide and worldwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA terminated this recall 44 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is there a risk of serious injury from this product?
The recall states it's an unapproved new drug, but the record does not describe specific injury risks.
Similar recalls
Latest food recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #F-1480-2018 (May 16, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for F-1480-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.